DERMA PHARM A/S: Financial statements 2020
CVR: 89453119
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
DERMA PHARM A/S (CVR 89453119) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 76,154,516 and a net result of DKK 11,970,764 compared with DKK 6,050,671 the year before. That is an increase of 20% compared with the year before. Equity in the 2020 report amounted to DKK 40,479,638. The solvency ratio was 47.2%. The company had 108 employees in the financial year.
- Gross Profit
- DKK 76,154,516
- Profit/Loss
- DKK 11,970,764
- Equity
- DKK 40,479,638
- Total Assets
- DKK 85,785,441
- Employees
- 108
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 76.2 mio. | 12 mio. | 40.5 mio. | 108 |
| 2019 | - | 63.5 mio. | 6.1 mio. | 32.6 mio. | 105 |
| 2018 | - | 52.4 mio. | 4.6 mio. | 30.7 mio. | 91 |
| 2017 | - | 47.6 mio. | 8.6 mio. | 31 mio. | 71 |
| 2016 | - | 43.2 mio. | 7.8 mio. | 22.4 mio. | 62 |
Official annual report
How creditworthy is DERMA PHARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
DERMA PHARM A/S has published its annual report for 2019. Gross profit came to DKK 63,481,838, and the net result was DKK 6,050,671.
About DERMA PHARM A/S
DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Mikkel Egelund Jensen and Peter Bogh. The board consists of Jean-Yves Paul Etienne Desmottes (chair), Magdalena Jurkiewicz, Marie Anne Louise Bozec and Massimiliano Costantini. The company is owned by DERMAPHARM HOLDING A/S. The company has 138 employees (2026). In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity in the 2025 report amounted to DKK 78,142,000.